Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

(COUV, OXGN, MSLP, LVLT, MTLK) Stock Report from CRWEFinance.com

crwefinancelogo2

chartstockalert

__

   COUV, Corporate Universe Inc., COUV.PK

COUV is a holding company formed in order to provide a greater range of services to the financial community.

COUV's services include, through our subsidiaries, a full service transfer agency, an EDGAR filing company, a press release company , a corporate printing company as well as a consulting group .

By providing multiple services COUV can provide "one stop" service at competitive prices.

Over the past decade, COUV has built close relationships with many companies in the financial marketplace who have made its global network both unique and competitive. COUV uses this network and its experience to provide high quality financial services to a global selection of corporate clients.

More about COUV at www.corp-universe.com

******************

Oxigene Inc. (Nasdaq:OXGN) a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, recently reported that it presented updated safety and clinical activity data from the FALCON trial, a randomized, controlled Phase 2 study of ZYBRESTAT(NYSE:TM) (CA4P) in patients with non-small cell lung cancer (NSCLC).

The updated analysis showed that the median time to progression for patients receiving ZYBRESTAT plus bevacizumab and chemotherapy was 9.5 months, compared with a median time to progression of 8.8 months for patients receiving bevacizumab and chemotherapy alone. Of the patients in the study arm (ZYBRESTAT combined with bevacizumab and carboplatin/paclitaxel chemotherapy), 50% achieved a partial response, compared with the control arm (bevacizumab and chemotherapy) of the trial, where only 38% of patients achieved a partial response. The combination regimen including ZYBRESTAT was observed to be well-tolerated with no significant cumulative toxicities when compared with the control arm of the study.

OXiGENE, Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat cancer and eye diseases in the United States. It primarily focuses on the development of product candidates that disable and destroy abnormal blood vessels that provide solid tumors a means of growth and survival, as well as associate with visual impairment in various ophthalmological diseases and conditions.

******************

   MSLP, MusclePharm Corporation, MSLP.OB

MSLP is a rapidly expanding healthy life-style company that develops and manufactures a full line of NSF and scientifically approved nutritional supplements that are 100% free of any banned substances.

MSLP reported that MusclePharm Athletes including UFC Star Rashad Evans, NFL Pittsburgh Steelers Hines Ward and Larry Foote will make appearances at Pennsylvania and Hawaii GNC locations in December.

MSLP has a multi-year partnership with the World Bodybuilding and Fitness Federation (WBFF) that will place the company as the title sponsor of the World Famous WBFF through 2014.

More about MSLP at www.musclepharm.com.

******************

Level 3 Communications Inc. (Nasdaq:LVLT) reported that it will present at the UBS 38th Annual Global Media and Communications Conference in New York on Wednesday, Dec. 8. Mr. Storey’s investor presentation is scheduled to begin at approximately 10 a.m. ET.

Level 3 Communications, Inc. (NASDAQ:LVLT) is a leading international provider of fiber-based communications services. Enterprise, content, wholesale and government customers rely on Level 3 to deliver services with an industry-leading combination of scalability and value over an end-to-end fiber network. Level 3 offers a portfolio of metro and long-haul services, including transport, data, Internet, content delivery and voice.

******************

Metalink, Ltd. (Nasdaq:MTLK) reported recently that its 2010 Annual General Meeting of Shareholders will be held on Friday, December 31, 2010, at 12:00 p.m. (Israel time), at the law offices of Goldfarb, Levy, Eran, Meiri, Tzafrir & Co., 2 Weizmann Street, Tel Aviv, Israel. The record date for the meeting is the close of business on November 29, 2010. Metalink will send to its shareholders of record a proxy statement describing the various matters to be voted upon at the meeting, along with a proxy card enabling them to indicate their vote on each matter. The Company will also furnish the proxy statement to the Securities and Exchange Commission (SEC) on Form 6-K.

Metalink, Ltd develops and provides wireless local area network (HT-WLAN) silicon solutions for telecommunications, networking, and home broadband equipment makers; and provides wireline broadband communication silicon solutions for telecommunications equipment makers worldwide.

********************************************************************

http://crwefinance.com/img/crwefinance_new_buscard2.jpg

Signup for FREE Daily Stock Alerts From http://www.CRWEFinance.com/signup

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWEFinance.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEFinance.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://crwefinance.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (OTCPK:CRWE) has received five thousand dollars and anticipates receiving another forty five thousand dollars in cash from a third party for 30 (thirty) days of advertising for Corporate Universe Inc., (OTCPK:COUV). Crown Equity Holdings Inc. (OTCPK:CRWE) has received five thousand dollars and anticipates receiving another forty five thousand dollars in cash from a third party for 30 (thirty) days of advertising for MusclePharm Corporation (OTCQB:MSLP).